BCM
GSK icon

Brookmont Capital Management’s GSK GSK Stock Holding History

Brookmont Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-146,291
Closed -$8.41M – 60
2014
Q3 		$8.41M Buy
146,291
+2,302
+2% +$141K 2.15% 30
2014
Q2 		$9.63M Buy
143,989
+16,309
+13% +$1.1M 2.32% 29
2014
Q1 		$8.53M Sell
127,680
-1,633
-1% -$110K 2.34% 31
2013
Q4 		$8.63M Buy
129,313
+12,796
+11% +$830K 2.38% 27
2013
Q3 		$7.31M Buy
116,517
+22,212
+24% +$1.43M 2.38% 29
2013
Q2 		$5.89M Buy
+94,305
New +$5.99M 2.44% 28

Other funds holding GSK

LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Brookmont Capital Management's GSK Position: Q4 2014 in Review

Brookmont Capital Management sold out of GSK (GSK) in Q4 2014, closing a stake of 146,291 shares — an estimated $8.41M sold.

Brookmont Capital Management first reported a position in GSK in Q2 2013 and held it in 6 quarters. The position peaked at $9.63M in Q2 2014. 729 funds tracked by Wall St. Rank hold GSK as of Q4 2014.

  • Brookmont Capital Management reported no remaining GSK position as of Q4 2014 after selling out during the quarter.
  • Brookmont Capital Management sold 146,291 GSK shares in Q4 2014, an estimated $8.41M.
  • Brookmont Capital Management first reported a position in GSK in Q2 2013 and held it in 6 quarters.
  • Brookmont Capital Management's GSK position peaked at $9.63M in Q2 2014.
  • 729 funds tracked by Wall St. Rank held GSK as of Q4 2014.

Based on Brookmont Capital Management's 13F filing for Q4 2014, filed 30 Jan 2015.